5F-ADBICA

5F-ADBICA is a topic that has captured the attention of people around the world. Since its appearance, it has generated great interest and has been the subject of numerous debates and discussions. Whether due to its relevance today or its historical impact, 5F-ADBICA continues to be an issue of great importance to society at large. In this article, we will explore in depth the different dimensions of 5F-ADBICA and its influence on different aspects of our lives. From its origins to its impact on popular culture, we'll look at how 5F-ADBICA has left its mark on history and how it continues to be relevant today.
5F-ADBICA
Legal status
Legal status
Identifiers
  • N--1-(5-fluoropentyl)indole-3-carboxamide
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC20H28FN3O2
Molar mass361.461 g·mol−1
3D model (JSmol)
  • CC(C)(C)(C(=O)N)NC(=O)C1=CN(C2=CC=CC=C21)CCCCCF
  • InChI=1S/C20H28FN3O2/c1-20(2,3)17(18(22)25)23-19(26)15-13-24(12-8-4-7-11-21)16-10-6-5-9-14(15)16/h5-6,9-10,13,17H,4,7-8,11-12H2,1-3H3,(H2,22,25)(H,23,26)/t17-/m1/s1
  • Key:ITZSOCZDFSHNCL-QGZVFWFLSA-N

5F-ADBICA (also known as 5F-ADB-PICA) is an indole-based synthetic cannabinoid that is a potent agonist at CB1 receptors and CB2 receptors with EC50 values of 0.77 nM and 1.2 nM respectively.[1][2]

E-cigarette sample containing 5F-ADBICA from a patient at the Poison Control Center of Bach Mai Hospital

China

As of October 2015 5F-ADBICA is a controlled substance in China.[3]

See also

References

  1. ^ Banister SD, Moir M, Stuart J, Kevin RC, Wood KE, Longworth M, et al. (September 2015). "Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA". ACS Chemical Neuroscience. 6 (9): 1546–59. doi:10.1021/acschemneuro.5b00112. PMID 26134475.
  2. ^ "5F-ADBICA". Southern Association of Forensic Scientists. Retrieved 21 July 2015.
  3. ^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Archived from the original on 1 October 2015. Retrieved 1 October 2015.